Skip to main content
Have a personal or library account? Click to login
Cost-Effectiveness Analysis of Etanercept in Combination with Methotrexate for Rheumatoid Arthritis - Markov Model Based on Data from Serbia Cover

Cost-Effectiveness Analysis of Etanercept in Combination with Methotrexate for Rheumatoid Arthritis - Markov Model Based on Data from Serbia

EABR. Experimental and Applied Biomedical Research
Volume 18 (2017): Issue 4 (December 2017)
By:   
Open Access
|Dec 2017
Article

Full Article

ABBREVIATIONS

ACR -

American College of Rheumatology

bDMARDs -

Biological Disease-modifying antirheumatic drugs

cDMARDS-

conventional DMARD-s

DAS28 -

Disease Activity Score

DMARDs -

Disease-modifying antirheumatic drugs

IL-1 -

Interleukin-1

IL-6 -

Interleukin-6

ICER -

Incremental cost-effectiveness ratio

HAQ -

Health Assessment Questionnaire

NICE -

National Institute for Clinical Excellence

QALY -

Quality-adjusted life year

RA -

Rheumatoid arthritis

DOI: https://doi.org/10.1515/sjecr-2016-0070 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)
Journal RSS Feed
Language: English
Page range: 343 - 347
Submitted on: Jul 5, 2016
Accepted on: Jul 28, 2016
Published on: Dec 29, 2017
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Keywords:
rheumatoid arthritis,
biological therapy,
etanercept,
cost-effectiveness analysis
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2017 Marina Kostic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 18 (2017): Issue 4 (December 2017)
Previous article
Next article